Transitional Cell Carcinoma Completed Phase 1 Trials for Sargramostim (DB00020)

Also known as: Carcinoma, Transitional Cell / Carcinoma transitional cell / Transitional cell carcinoma (morphologic abnormality)

IndicationStatusPhase
DBCOND0031000 (Transitional Cell Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00070070Vaccine Therapy in Treating Patients With Transitional Cell CarcinomasTreatment